Capricor Therapeutics, Inc. (CAPR)
28.70
-1.11
(-3.72%)
USD |
NASDAQ |
May 15, 12:06
Capricor Therapeutics EPS Diluted (Quarterly) : -0.591 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Vaxart, Inc. | 0.0214 |
| Allogene Therapeutics, Inc. | -0.1773 |
| REGENXBIO, Inc. | -1.718 |
| Replimune Group, Inc. | -0.7694 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.94M |
| Total Expenses (Quarterly) | 33.94M |
| Enterprise Value | 1.469B |
| Earnings Yield | -8.06% |
| Normalized Earnings Yield | -8.059 |